anamorelin: Clinical Trials

5 trials of anamorelin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 completed, 1 terminated. 3 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 2, Terminated 1
Phase 32Active not recruiting 1, Completed 1
Phase 11Completed 1

Follow anamorelin: new trials by email Literature Review of anamorelin trials Research Report on anamorelin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anamorelin Study for Advanced Pancreatic Cancer
Anamorelin Hydrochloride, Placebo - Metastatic Pancreatic Cancer
Phase 2TerminatedLahey Clinic42023-04-012025-11-17
Effect of a Ghrelin Receptor Agonist on Muscle and Bone
Anamorelin Hydrochloride, Placebo - Sarcopenia, Osteopenia
Phase 1CompletedTufts University322019-12-052024-03-27
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 1
Anamorelin Hydrochloride, Placebo Oral Tablet - Cachexia; Cancer, Non Small Cell Lung Cancer
Phase 3CompletedHelsinn Healthcare SA3182019-03-052026-10-06
Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer
Anamorelin Hydrochloride, Placebo, Questionnaire Administration - Anorexia, Lung Non-Small Cell Carcinoma
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center252018-11-272026-10-06
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
Anamorelin Hydrochloride, Exercise Intervention, Laboratory Biomarker Analysis - Advanced Malignant Solid Neoplasm, C-Reactive Protein Measurement
Phase 2Active not recruitingM.D. Anderson Cancer Center1292017-02-082026-06-18

Conditions studied

Anorexia (2)  ·  Cachexia (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Weight Loss (2)  ·  Bone Diseases, Metabolic (1)  ·  Lung Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcopenia (1)

Sponsors

M.D. Anderson Cancer Center (2)  ·  Helsinn Healthcare SA (1)  ·  Lahey Clinic (1)  ·  Tufts University (1)

Countries

United States (5)  ·  Bulgaria (1)  ·  Hungary (1)  ·  Italy (1)  ·  Romania (1)  ·  Russia (1)  ·  Serbia (1)

Top investigators

Sriram Yennu (2)  ·  Bess Dawson-Hughes, MD (1)  ·  Keith Stuart (1)

Results publications

PMID 34331589, PMID 38197040

NIH funding

2018 (1), R21AR074138 (1)